CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
63.48
-1.61 (-2.47%)
At close: Feb 21, 2025, 4:00 PM
63.36
-0.12 (-0.20%)
After-hours: Feb 21, 2025, 7:50 PM EST
CVS Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 370,656 | 356,623 | 321,629 | 290,912 | 267,908 | Upgrade
|
| Revenue Growth (YoY) | 3.93% | 10.88% | 10.56% | 8.59% | 4.75% | Upgrade
|
| Cost of Revenue | 321,408 | 303,345 | 267,965 | 239,991 | 219,660 | Upgrade
|
| Gross Profit | 49,248 | 53,278 | 53,664 | 50,921 | 48,248 | Upgrade
|
| Selling, General & Admin | 41,229 | 39,205 | 37,922 | 36,764 | 34,585 | Upgrade
|
| Operating Expenses | 41,229 | 39,205 | 37,922 | 36,764 | 34,585 | Upgrade
|
| Operating Income | 8,019 | 14,073 | 15,742 | 14,157 | 13,663 | Upgrade
|
| Interest Expense | -2,958 | -2,658 | -2,287 | -2,503 | -2,907 | Upgrade
|
| Interest & Investment Income | 2,153 | 1,153 | 838 | 1,199 | 798 | Upgrade
|
| Other Non Operating Income (Expenses) | -5 | -6 | -4 | -4 | -12 | Upgrade
|
| EBT Excluding Unusual Items | 7,209 | 12,562 | 14,289 | 12,849 | 11,542 | Upgrade
|
| Merger & Restructuring Charges | -1,452 | -1,040 | -117 | -1,490 | -332 | Upgrade
|
| Impairment of Goodwill | - | - | - | -431 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -349 | -2,533 | - | - | Upgrade
|
| Legal Settlements | -100 | - | -5,803 | - | - | Upgrade
|
| Other Unusual Items | 491 | - | - | -391 | -1,440 | Upgrade
|
| Pretax Income | 6,148 | 11,173 | 5,836 | 10,537 | 9,770 | Upgrade
|
| Income Tax Expense | 1,562 | 2,805 | 1,509 | 2,548 | 2,569 | Upgrade
|
| Earnings From Continuing Operations | 4,586 | 8,368 | 4,327 | 7,989 | 7,201 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | -9 | Upgrade
|
| Net Income to Company | 4,586 | 8,368 | 4,327 | 7,989 | 7,192 | Upgrade
|
| Minority Interest in Earnings | 28 | -24 | -16 | 12 | -13 | Upgrade
|
| Net Income | 4,614 | 8,344 | 4,311 | 8,001 | 7,179 | Upgrade
|
| Net Income to Common | 4,614 | 8,344 | 4,311 | 8,001 | 7,179 | Upgrade
|
| Net Income Growth | -44.70% | 93.55% | -46.12% | 11.45% | 8.22% | Upgrade
|
| Shares Outstanding (Basic) | 1,259 | 1,285 | 1,312 | 1,319 | 1,309 | Upgrade
|
| Shares Outstanding (Diluted) | 1,262 | 1,290 | 1,323 | 1,329 | 1,314 | Upgrade
|
| Shares Change (YoY) | -2.17% | -2.49% | -0.45% | 1.14% | 0.69% | Upgrade
|
| EPS (Basic) | 3.66 | 6.49 | 3.29 | 6.07 | 5.48 | Upgrade
|
| EPS (Diluted) | 3.66 | 6.47 | 3.26 | 6.02 | 5.46 | Upgrade
|
| EPS Growth | -43.43% | 98.47% | -45.85% | 10.19% | 7.54% | Upgrade
|
| Free Cash Flow | 6,326 | 10,395 | 13,450 | 15,745 | 13,428 | Upgrade
|
| Free Cash Flow Per Share | 5.01 | 8.06 | 10.17 | 11.85 | 10.22 | Upgrade
|
| Dividend Per Share | 2.660 | 2.420 | 2.200 | 2.000 | 2.000 | Upgrade
|
| Dividend Growth | 9.92% | 10.00% | 10.00% | 0% | 0% | Upgrade
|
| Gross Margin | 13.29% | 14.94% | 16.68% | 17.50% | 18.01% | Upgrade
|
| Operating Margin | 2.16% | 3.95% | 4.89% | 4.87% | 5.10% | Upgrade
|
| Profit Margin | 1.24% | 2.34% | 1.34% | 2.75% | 2.68% | Upgrade
|
| Free Cash Flow Margin | 1.71% | 2.91% | 4.18% | 5.41% | 5.01% | Upgrade
|
| EBITDA | 12,616 | 18,439 | 19,966 | 18,643 | 18,104 | Upgrade
|
| EBITDA Margin | 3.40% | 5.17% | 6.21% | 6.41% | 6.76% | Upgrade
|
| D&A For EBITDA | 4,597 | 4,366 | 4,224 | 4,486 | 4,441 | Upgrade
|
| EBIT | 8,019 | 14,073 | 15,742 | 14,157 | 13,663 | Upgrade
|
| EBIT Margin | 2.16% | 3.95% | 4.89% | 4.87% | 5.10% | Upgrade
|
| Effective Tax Rate | 25.41% | 25.11% | 25.86% | 24.18% | 26.29% | Upgrade
|
| Revenue as Reported | 372,809 | 357,776 | 322,467 | 292,111 | 268,706 | Upgrade
|
| Advertising Expenses | 989 | 985 | 745 | 707 | 613 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.